Extracellular Vesicles (EVs) Derived from Mesenchymal Stem Cells (MSCs) as Adjuvants in the Treatment of Chronic Kidney Disease (CKD)

Extracellular Vesicles (EVs) Derived from Mesenchymal Stem Cells (MSCs) as Adjuvants in the Treatment of Chronic Kidney Disease (CKD)

Chronic kidney disease (CKD) is considered an important health issue worldwide. The renin–angiotensin–aldosterone system (RAAS) blockade through the administration of angiotensin II receptor blockers, such as Losartan (LOS), has been considered the best strategy for CKD treatment for decades. Howeve...

Full description

Saved in:
Bibliographic Details
Main Authors: Paloma Noda, Ana L. R. Francini, Flavio Teles, Samuel J. Júnior, Fernando L. A. Fonseca, Fernanda T. Borges, Adão C. Sobrinho, Noemi Taniwaki, Irene L. Noronha, Camilla Fanelli
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Cells
Subjects:
extracellular vesicles
chronic kidney disease
cell therapy
mesenchymal stem cells
Online Access:https://www.mdpi.com/2073-4409/14/6/434
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/14/6/434

Similar Items